Oklahoma Life Science Fund

Cadenza Bio is a biotechnology company focused on the development of highly selective small-molecule drugs aimed at treating demyelinating and inflammatory diseases. The company is dedicated to creating therapeutic medications that not only alleviate symptoms but also halt disease progression, promote repair, and restore the quality of life for patients. By advancing a new class of Estrogen Receptor targeted small molecules, Cadenza Bio aims to empower patients to regain control over their health and improve their overall well-being.

Mate Fertility is a California-based company that operates tech-enabled fertility clinics, founded in 2020 and headquartered in Los Angeles. The company aims to make parenthood more accessible by providing affordable fertility services. It offers a platform that connects patients to various fertility clinics and telemedicine options for treatments and therapies. Additionally, Mate Fertility provides comprehensive fertility services, including expert advice and treatment from qualified doctors, ensuring patients receive both support and guidance throughout their fertility journey.

Access Optics specializes in the manufacturing of precision and micro-scale optics tailored for applications in tiny cameras and medical equipment, particularly endoscopic devices. The company combines innovative engineering, process development, and optical fabrication with advanced coating technologies to create high-performance optical assemblies and micro-scale surgical imaging products. Designed to withstand extreme pressures, temperatures, and humidity, these products include hermetic seals that enhance the reliability of medical instruments. Access Optics' commitment to pioneering product development and advanced materials solutions has positioned it as a key supplier for leading original equipment manufacturers in sectors such as endoscopy, dermatology, aerospace, and chromatography, ultimately contributing to improved surgical outcomes.

Recuro Health is a developer of an integrated digital health platform that aims to transform the U.S. healthcare system from a reactive, disease-focused model to one centered on population health and outcomes. The company provides a tailored Digital Medical Home that caters to specific healthcare needs, offering essential virtual care services, including primary care, behavioral health, and urgent care. By equipping employers, providers, and managed care organizations with various digital tools, education, and guidance, Recuro Health enables patients to actively engage in their healthcare through health assessments and interactive communication with professionals, whether via messaging or video. This approach seeks to enhance patient involvement and improve health outcomes across diverse settings.

Recuro Health is a developer of an integrated digital health platform that aims to transform the U.S. healthcare system from a reactive, disease-focused model to one centered on population health and outcomes. The company provides a tailored Digital Medical Home that caters to specific healthcare needs, offering essential virtual care services, including primary care, behavioral health, and urgent care. By equipping employers, providers, and managed care organizations with various digital tools, education, and guidance, Recuro Health enables patients to actively engage in their healthcare through health assessments and interactive communication with professionals, whether via messaging or video. This approach seeks to enhance patient involvement and improve health outcomes across diverse settings.

AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.

AliveCor, Inc. specializes in developing digital medical-grade electrocardiograms, enabling users to monitor their heart health through mobile technology. The company's flagship product, KardiaMobile, is a personal mobile EKG device that provides instant detection of common heart arrhythmias, along with features for blood pressure and weight tracking, as well as storage for recorded EKGs. Additionally, AliveCor offers KardiaMobile 6L, a six-lead EKG device that allows patients to share detailed EKG readings with healthcare providers. The company also operates KardiaCare, a digital health subscription service that empowers users to manage their heart health conveniently at home. Founded in 2010 and incorporated in 2011, AliveCor is headquartered in Mountain View, California, and is recognized for its innovative contributions to cardiac care through the integration of machine learning techniques.